2023-2028 Global and Regional Gastrointestinal Stromal Tumor (GIST) Drug Industry Status and Prospects Professional Market Research Report Standard Version
The global Gastrointestinal Stromal Tumor (GIST) Drug market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Ariad Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc.
Array BioPharma Inc.
Astex Pharmaceuticals, Inc.
Blueprint Medicines Corporation
Boston Biomedical, Inc.
Calithera Biosciences, Inc.
Chipscreen Biosciences Ltd
Deciphera Pharmaceuticals, LLC
F. Hoffmann-La Roche Ltd.
Horizon Pharma Plc
Immunicum AB
Jiangsu Hengrui Medicine Co., Ltd.
Kolltan Pharmaceuticals, Inc.
Natco Pharma Limited
Nerviano Medical Sciences S.r.l.
Novartis AG
Omeros Corporation
By Types:
Amcasertib
Anagrelide hydrochloride CR
APG-1351
Binimetinib
Others
By Applications:
Clinic
Hospital
Others
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Ariad Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc.
Array BioPharma Inc.
Astex Pharmaceuticals, Inc.
Blueprint Medicines Corporation
Boston Biomedical, Inc.
Calithera Biosciences, Inc.
Chipscreen Biosciences Ltd
Deciphera Pharmaceuticals, LLC
F. Hoffmann-La Roche Ltd.
Horizon Pharma Plc
Immunicum AB
Jiangsu Hengrui Medicine Co., Ltd.
Kolltan Pharmaceuticals, Inc.
Natco Pharma Limited
Nerviano Medical Sciences S.r.l.
Novartis AG
Omeros Corporation
By Types:
Amcasertib
Anagrelide hydrochloride CR
APG-1351
Binimetinib
Others
By Applications:
Clinic
Hospital
Others
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
CHAPTER 1 INDUSTRY OVERVIEW
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Analysis from 2023 to 2028
1.5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Gastrointestinal Stromal Tumor (GIST) Drug Industry Impact
CHAPTER 2 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG COMPETITION BY TYPES, APPLICATIONS, AND TOP REGIONS AND COUNTRIES
2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug (Volume and Value) by Type
2.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Market Share by Type (2017-2022)
2.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Type (2017-2022)
2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug (Volume and Value) by Application
2.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Market Share by Application (2017-2022)
2.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Application (2017-2022)
2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug (Volume and Value) by Regions
2.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Regions (2017-2022)
CHAPTER 3 PRODUCTION MARKET ANALYSIS
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
CHAPTER 4 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG SALES, CONSUMPTION, EXPORT, IMPORT BY REGIONS (2017-2022)
4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Regions (2017-2022)
4.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
4.10 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
CHAPTER 5 NORTH AMERICA GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET ANALYSIS
5.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Value Analysis
5.1.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Under COVID-19
5.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
5.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
5.4 North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Top Countries
5.4.1 United States Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
5.4.2 Canada Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
5.4.3 Mexico Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
CHAPTER 6 EAST ASIA GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET ANALYSIS
6.1 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Value Analysis
6.1.1 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Under COVID-19
6.2 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
6.3 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
6.4 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Top Countries
6.4.1 China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
6.4.2 Japan Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
6.4.3 South Korea Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
CHAPTER 7 EUROPE GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET ANALYSIS
7.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Value Analysis
7.1.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Under COVID-19
7.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
7.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
7.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Top Countries
7.4.1 Germany Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
7.4.2 UK Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
7.4.3 France Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
7.4.4 Italy Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
7.4.5 Russia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
7.4.6 Spain Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
7.4.7 Netherlands Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
7.4.8 Switzerland Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
7.4.9 Poland Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
CHAPTER 8 SOUTH ASIA GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET ANALYSIS
8.1 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Value Analysis
8.1.1 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Under COVID-19
8.2 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
8.3 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
8.4 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Top Countries
8.4.1 India Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
8.4.2 Pakistan Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
CHAPTER 9 SOUTHEAST ASIA GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET ANALYSIS
9.1 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Value Analysis
9.1.1 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Under COVID-19
9.2 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
9.3 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
9.4 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Top Countries
9.4.1 Indonesia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
9.4.2 Thailand Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
9.4.3 Singapore Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
9.4.4 Malaysia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
9.4.5 Philippines Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
9.4.6 Vietnam Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
9.4.7 Myanmar Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
CHAPTER 10 MIDDLE EAST GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET ANALYSIS
10.1 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Value Analysis
10.1.1 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Market Under COVID-19
10.2 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
10.3 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
10.4 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Top Countries
10.4.1 Turkey Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
10.4.3 Iran Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
10.4.5 Israel Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
10.4.6 Iraq Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
10.4.7 Qatar Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
10.4.8 Kuwait Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
10.4.9 Oman Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
CHAPTER 11 AFRICA GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET ANALYSIS
11.1 Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Value Analysis
11.1.1 Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Under COVID-19
11.2 Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
11.3 Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
11.4 Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Top Countries
11.4.1 Nigeria Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
11.4.2 South Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
11.4.3 Egypt Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
11.4.4 Algeria Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
11.4.5 Morocco Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
CHAPTER 12 OCEANIA GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET ANALYSIS
12.1 Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Value Analysis
12.2 Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
12.3 Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
12.4 Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Top Countries
12.4.1 Australia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
12.4.2 New Zealand Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
CHAPTER 13 SOUTH AMERICA GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET ANALYSIS
13.1 South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Value Analysis
13.1.1 South America Gastrointestinal Stromal Tumor (GIST) Drug Market Under COVID-19
13.2 South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
13.3 South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
13.4 South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Major Countries
13.4.1 Brazil Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
13.4.2 Argentina Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
13.4.3 Columbia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
13.4.4 Chile Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
13.4.5 Venezuela Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
13.4.6 Peru Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
13.4.8 Ecuador Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
CHAPTER 14 COMPANY PROFILES AND KEY FIGURES IN GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG BUSINESS
14.1 Ariad Pharmaceuticals, Inc.
14.1.1 Ariad Pharmaceuticals, Inc. Company Profile
14.1.2 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Arog Pharmaceuticals, Inc.
14.2.1 Arog Pharmaceuticals, Inc. Company Profile
14.2.2 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Array BioPharma Inc.
14.3.1 Array BioPharma Inc. Company Profile
14.3.2 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Astex Pharmaceuticals, Inc.
14.4.1 Astex Pharmaceuticals, Inc. Company Profile
14.4.2 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Blueprint Medicines Corporation
14.5.1 Blueprint Medicines Corporation Company Profile
14.5.2 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Boston Biomedical, Inc.
14.6.1 Boston Biomedical, Inc. Company Profile
14.6.2 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Calithera Biosciences, Inc.
14.7.1 Calithera Biosciences, Inc. Company Profile
14.7.2 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Chipscreen Biosciences Ltd
14.8.1 Chipscreen Biosciences Ltd Company Profile
14.8.2 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Deciphera Pharmaceuticals, LLC
14.9.1 Deciphera Pharmaceuticals, LLC Company Profile
14.9.2 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 F. Hoffmann-La Roche Ltd.
14.10.1 F. Hoffmann-La Roche Ltd. Company Profile
14.10.2 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Horizon Pharma Plc
14.11.1 Horizon Pharma Plc Company Profile
14.11.2 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.11.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 Immunicum AB
14.12.1 Immunicum AB Company Profile
14.12.2 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.12.3 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 Jiangsu Hengrui Medicine Co., Ltd.
14.13.1 Jiangsu Hengrui Medicine Co., Ltd. Company Profile
14.13.2 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.13.3 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.14 Kolltan Pharmaceuticals, Inc.
14.14.1 Kolltan Pharmaceuticals, Inc. Company Profile
14.14.2 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.14.3 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.15 Natco Pharma Limited
14.15.1 Natco Pharma Limited Company Profile
14.15.2 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.15.3 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.16 Nerviano Medical Sciences S.r.l.
14.16.1 Nerviano Medical Sciences S.r.l. Company Profile
14.16.2 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.16.3 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.17 Novartis AG
14.17.1 Novartis AG Company Profile
14.17.2 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.17.3 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.18 Omeros Corporation
14.18.1 Omeros Corporation Company Profile
14.18.2 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.18.3 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
CHAPTER 15 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET FORECAST (2023-2028)
15.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
15.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast by Type (2023-2028)
15.3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Type (2023-2028)
15.3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price Forecast by Type (2023-2028)
15.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume Forecast by Application (2023-2028)
15.5 Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast Under COVID-19
CHAPTER 16 CONCLUSIONS
Research Methodology
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Analysis from 2023 to 2028
1.5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Gastrointestinal Stromal Tumor (GIST) Drug Industry Impact
CHAPTER 2 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG COMPETITION BY TYPES, APPLICATIONS, AND TOP REGIONS AND COUNTRIES
2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug (Volume and Value) by Type
2.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Market Share by Type (2017-2022)
2.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Type (2017-2022)
2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug (Volume and Value) by Application
2.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Market Share by Application (2017-2022)
2.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Application (2017-2022)
2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug (Volume and Value) by Regions
2.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Regions (2017-2022)
CHAPTER 3 PRODUCTION MARKET ANALYSIS
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
CHAPTER 4 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG SALES, CONSUMPTION, EXPORT, IMPORT BY REGIONS (2017-2022)
4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Regions (2017-2022)
4.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
4.10 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
CHAPTER 5 NORTH AMERICA GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET ANALYSIS
5.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Value Analysis
5.1.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Under COVID-19
5.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
5.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
5.4 North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Top Countries
5.4.1 United States Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
5.4.2 Canada Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
5.4.3 Mexico Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
CHAPTER 6 EAST ASIA GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET ANALYSIS
6.1 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Value Analysis
6.1.1 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Under COVID-19
6.2 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
6.3 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
6.4 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Top Countries
6.4.1 China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
6.4.2 Japan Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
6.4.3 South Korea Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
CHAPTER 7 EUROPE GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET ANALYSIS
7.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Value Analysis
7.1.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Under COVID-19
7.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
7.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
7.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Top Countries
7.4.1 Germany Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
7.4.2 UK Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
7.4.3 France Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
7.4.4 Italy Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
7.4.5 Russia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
7.4.6 Spain Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
7.4.7 Netherlands Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
7.4.8 Switzerland Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
7.4.9 Poland Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
CHAPTER 8 SOUTH ASIA GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET ANALYSIS
8.1 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Value Analysis
8.1.1 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Under COVID-19
8.2 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
8.3 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
8.4 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Top Countries
8.4.1 India Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
8.4.2 Pakistan Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
CHAPTER 9 SOUTHEAST ASIA GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET ANALYSIS
9.1 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Value Analysis
9.1.1 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Under COVID-19
9.2 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
9.3 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
9.4 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Top Countries
9.4.1 Indonesia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
9.4.2 Thailand Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
9.4.3 Singapore Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
9.4.4 Malaysia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
9.4.5 Philippines Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
9.4.6 Vietnam Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
9.4.7 Myanmar Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
CHAPTER 10 MIDDLE EAST GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET ANALYSIS
10.1 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Value Analysis
10.1.1 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Market Under COVID-19
10.2 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
10.3 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
10.4 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Top Countries
10.4.1 Turkey Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
10.4.3 Iran Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
10.4.5 Israel Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
10.4.6 Iraq Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
10.4.7 Qatar Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
10.4.8 Kuwait Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
10.4.9 Oman Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
CHAPTER 11 AFRICA GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET ANALYSIS
11.1 Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Value Analysis
11.1.1 Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Under COVID-19
11.2 Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
11.3 Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
11.4 Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Top Countries
11.4.1 Nigeria Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
11.4.2 South Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
11.4.3 Egypt Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
11.4.4 Algeria Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
11.4.5 Morocco Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
CHAPTER 12 OCEANIA GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET ANALYSIS
12.1 Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Value Analysis
12.2 Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
12.3 Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
12.4 Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Top Countries
12.4.1 Australia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
12.4.2 New Zealand Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
CHAPTER 13 SOUTH AMERICA GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET ANALYSIS
13.1 South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Value Analysis
13.1.1 South America Gastrointestinal Stromal Tumor (GIST) Drug Market Under COVID-19
13.2 South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
13.3 South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
13.4 South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Major Countries
13.4.1 Brazil Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
13.4.2 Argentina Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
13.4.3 Columbia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
13.4.4 Chile Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
13.4.5 Venezuela Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
13.4.6 Peru Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
13.4.8 Ecuador Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
CHAPTER 14 COMPANY PROFILES AND KEY FIGURES IN GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG BUSINESS
14.1 Ariad Pharmaceuticals, Inc.
14.1.1 Ariad Pharmaceuticals, Inc. Company Profile
14.1.2 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Arog Pharmaceuticals, Inc.
14.2.1 Arog Pharmaceuticals, Inc. Company Profile
14.2.2 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Array BioPharma Inc.
14.3.1 Array BioPharma Inc. Company Profile
14.3.2 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Astex Pharmaceuticals, Inc.
14.4.1 Astex Pharmaceuticals, Inc. Company Profile
14.4.2 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Blueprint Medicines Corporation
14.5.1 Blueprint Medicines Corporation Company Profile
14.5.2 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Boston Biomedical, Inc.
14.6.1 Boston Biomedical, Inc. Company Profile
14.6.2 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Calithera Biosciences, Inc.
14.7.1 Calithera Biosciences, Inc. Company Profile
14.7.2 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Chipscreen Biosciences Ltd
14.8.1 Chipscreen Biosciences Ltd Company Profile
14.8.2 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Deciphera Pharmaceuticals, LLC
14.9.1 Deciphera Pharmaceuticals, LLC Company Profile
14.9.2 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 F. Hoffmann-La Roche Ltd.
14.10.1 F. Hoffmann-La Roche Ltd. Company Profile
14.10.2 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Horizon Pharma Plc
14.11.1 Horizon Pharma Plc Company Profile
14.11.2 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.11.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 Immunicum AB
14.12.1 Immunicum AB Company Profile
14.12.2 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.12.3 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 Jiangsu Hengrui Medicine Co., Ltd.
14.13.1 Jiangsu Hengrui Medicine Co., Ltd. Company Profile
14.13.2 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.13.3 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.14 Kolltan Pharmaceuticals, Inc.
14.14.1 Kolltan Pharmaceuticals, Inc. Company Profile
14.14.2 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.14.3 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.15 Natco Pharma Limited
14.15.1 Natco Pharma Limited Company Profile
14.15.2 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.15.3 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.16 Nerviano Medical Sciences S.r.l.
14.16.1 Nerviano Medical Sciences S.r.l. Company Profile
14.16.2 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.16.3 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.17 Novartis AG
14.17.1 Novartis AG Company Profile
14.17.2 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.17.3 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.18 Omeros Corporation
14.18.1 Omeros Corporation Company Profile
14.18.2 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
14.18.3 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
CHAPTER 15 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET FORECAST (2023-2028)
15.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
15.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast by Type (2023-2028)
15.3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Type (2023-2028)
15.3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price Forecast by Type (2023-2028)
15.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume Forecast by Application (2023-2028)
15.5 Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast Under COVID-19
CHAPTER 16 CONCLUSIONS
Research Methodology
LIST OF TABLES AND FIGURES
Figure Product Picture
Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Canada Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Mexico Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure East Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure China Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Japan Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure South Korea Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Germany Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure UK Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure France Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Italy Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Russia Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Spain Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Netherlands Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Switzerland Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Poland Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure South Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure India Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Pakistan Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Bangladesh Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Indonesia Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Thailand Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Singapore Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Malaysia Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Philippines Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Vietnam Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Myanmar Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Middle East Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Turkey Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Saudi Arabia Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Iran Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure United Arab Emirates Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Israel Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Iraq Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Qatar Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Kuwait Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Oman Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Nigeria Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure South Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Egypt Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Algeria Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Algeria Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Oceania Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Australia Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure New Zealand Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Brazil Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Argentina Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Columbia Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Chile Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Venezuela Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Peru Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Puerto Rico Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Ecuador Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Analysis from 2023 to 2028 by Consumption Volume
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Analysis from 2023 to 2028 by Value
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Price Trends Analysis from 2023 to 2028
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Market Share by Type (2017-2022)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Type (2017-2022)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Market Share by Application (2017-2022)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Application (2017-2022)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Market Share by Regions (2017-2022)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Regions (2017-2022)
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Major Manufacturers Capacity and Total Capacity
Table 2017-2022 Major Manufacturers Capacity Market Share
Table 2017-2022 Major Manufacturers Production and Total Production
Table 2017-2022 Major Manufacturers Production Market Share
Table 2017-2022 Major Manufacturers Revenue and Total Revenue
Table 2017-2022 Major Manufacturers Revenue Market Share
Table 2017-2022 Regional Market Capacity and Market Share
Table 2017-2022 Regional Market Production and Market Share
Table 2017-2022 Regional Market Revenue and Market Share
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Regions (2017-2022)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Regions (2017-2022)
Table North America Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
Table East Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
Table Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
Table South Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
Table Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
Table Middle East Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
Table Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
Table Oceania Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
Table South America Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2017-2022)
Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2017-2022)
Table North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Price Analysis (2017-2022)
Table North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
Table North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
Table North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Top Countries
Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Canada Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Mexico Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2017-2022)
Figure East Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2017-2022)
Table East Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales Price Analysis (2017-2022)
Table East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
Table East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
Table East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Top Countries
Figure China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Japan Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure South Korea Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2017-2022)
Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2017-2022)
Table Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Price Analysis (2017-2022)
Table Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
Table Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
Table Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Top Countries
Figure Germany Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure UK Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure France Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Italy Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Russia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Spain Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Netherlands Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Switzerland Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Poland Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2017-2022)
Figure South Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2017-2022)
Table South Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales Price Analysis (2017-2022)
Table South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
Table South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
Table South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Top Countries
Figure India Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Pakistan Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Bangladesh Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2017-2022)
Figure Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2017-2022)
Table Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales Price Analysis (2017-2022)
Table Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
Table Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
Table Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Top Countries
Figure Indonesia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Thailand Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Singapore Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Malaysia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Philippines Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Vietnam Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Myanmar Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2017-2022)
Figure Middle East Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2017-2022)
Table Middle East Gastrointestinal Stromal Tumor (GIST) Drug Sales Price Analysis (2017-2022)
Table Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
Table Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
Table Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Top Countries
Figure Turkey Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Saudi Arabia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Iran Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure United Arab Emirates Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Israel Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Iraq Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Qatar Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Kuwait Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Oman Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2017-2022)
Figure Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2017-2022)
Table Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Price Analysis (2017-2022)
Table Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
Table Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
Table Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Top Countries
Figure Nigeria Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure South Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Egypt Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Algeria Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Algeria Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2017-2022)
Figure Oceania Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2017-2022)
Table Oceania Gastrointestinal Stromal Tumor (GIST) Drug Sales Price Analysis (2017-2022)
Table Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
Table Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
Table Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Top Countries
Figure Australia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure New Zealand Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2017-2022)
Figure South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2017-2022)
Table South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Price Analysis (2017-2022)
Table South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
Table South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
Table South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Major Countries
Figure Brazil Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Argentina Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Columbia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Chile Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Venezuela Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Peru Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Puerto Rico Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Ecuador Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume and Growth Rate Forecast (2023-2028)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume Forecast by Regions (2023-2028)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Value Forecast by Regions (2023-2028)
Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Canada Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Canada Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Mexico Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Mexico Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure East Asia Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure China Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure China Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Japan Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Japan Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure South Korea Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure South Korea Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Germany Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Germany Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure UK Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure UK Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure France Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure France Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Italy Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Italy Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Russia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Russia Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Spain Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Spain Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Netherlands Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Netherlands Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Swizerland Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Swizerland Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Poland Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Poland Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure South Asia a Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure India Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure India Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Pakistan Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Pakistan Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Bangladesh Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Bangladesh Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Indonesia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Indonesia Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Thailand Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Thailand Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Singapore Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Singapore Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Malaysia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Malaysia Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Philippines Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Philippines Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Vietnam Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Vietnam Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Myanmar Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Myanmar Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Middle Eas
Figure Product Picture
Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Canada Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Mexico Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure East Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure China Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Japan Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure South Korea Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Germany Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure UK Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure France Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Italy Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Russia Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Spain Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Netherlands Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Switzerland Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Poland Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure South Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure India Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Pakistan Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Bangladesh Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Indonesia Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Thailand Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Singapore Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Malaysia Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Philippines Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Vietnam Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Myanmar Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Middle East Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Turkey Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Saudi Arabia Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Iran Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure United Arab Emirates Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Israel Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Iraq Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Qatar Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Kuwait Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Oman Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Nigeria Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure South Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Egypt Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Algeria Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Algeria Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Oceania Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Australia Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure New Zealand Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Brazil Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Argentina Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Columbia Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Chile Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Venezuela Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Peru Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Puerto Rico Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Ecuador Gastrointestinal Stromal Tumor (GIST) Drug Revenue ($) and Growth Rate (2023-2028)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Analysis from 2023 to 2028 by Consumption Volume
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Analysis from 2023 to 2028 by Value
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Price Trends Analysis from 2023 to 2028
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Market Share by Type (2017-2022)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Type (2017-2022)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Market Share by Application (2017-2022)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Application (2017-2022)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Market Share by Regions (2017-2022)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Regions (2017-2022)
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Major Manufacturers Capacity and Total Capacity
Table 2017-2022 Major Manufacturers Capacity Market Share
Table 2017-2022 Major Manufacturers Production and Total Production
Table 2017-2022 Major Manufacturers Production Market Share
Table 2017-2022 Major Manufacturers Revenue and Total Revenue
Table 2017-2022 Major Manufacturers Revenue Market Share
Table 2017-2022 Regional Market Capacity and Market Share
Table 2017-2022 Regional Market Production and Market Share
Table 2017-2022 Regional Market Revenue and Market Share
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Regions (2017-2022)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Regions (2017-2022)
Table North America Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
Table East Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
Table Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
Table South Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
Table Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
Table Middle East Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
Table Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
Table Oceania Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
Table South America Gastrointestinal Stromal Tumor (GIST) Drug Sales, Consumption, Export, Import (2017-2022)
Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2017-2022)
Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2017-2022)
Table North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Price Analysis (2017-2022)
Table North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
Table North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
Table North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Top Countries
Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Canada Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Mexico Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2017-2022)
Figure East Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2017-2022)
Table East Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales Price Analysis (2017-2022)
Table East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
Table East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
Table East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Top Countries
Figure China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Japan Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure South Korea Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2017-2022)
Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2017-2022)
Table Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Price Analysis (2017-2022)
Table Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
Table Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
Table Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Top Countries
Figure Germany Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure UK Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure France Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Italy Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Russia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Spain Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Netherlands Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Switzerland Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Poland Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2017-2022)
Figure South Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2017-2022)
Table South Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales Price Analysis (2017-2022)
Table South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
Table South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
Table South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Top Countries
Figure India Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Pakistan Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Bangladesh Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2017-2022)
Figure Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2017-2022)
Table Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales Price Analysis (2017-2022)
Table Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
Table Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
Table Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Top Countries
Figure Indonesia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Thailand Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Singapore Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Malaysia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Philippines Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Vietnam Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Myanmar Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2017-2022)
Figure Middle East Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2017-2022)
Table Middle East Gastrointestinal Stromal Tumor (GIST) Drug Sales Price Analysis (2017-2022)
Table Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
Table Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
Table Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Top Countries
Figure Turkey Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Saudi Arabia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Iran Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure United Arab Emirates Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Israel Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Iraq Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Qatar Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Kuwait Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Oman Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2017-2022)
Figure Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2017-2022)
Table Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Price Analysis (2017-2022)
Table Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
Table Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
Table Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Top Countries
Figure Nigeria Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure South Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Egypt Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Algeria Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Algeria Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2017-2022)
Figure Oceania Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2017-2022)
Table Oceania Gastrointestinal Stromal Tumor (GIST) Drug Sales Price Analysis (2017-2022)
Table Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
Table Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
Table Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Top Countries
Figure Australia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure New Zealand Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2017-2022)
Figure South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2017-2022)
Table South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Price Analysis (2017-2022)
Table South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Types
Table South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Structure by Application
Table South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume by Major Countries
Figure Brazil Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Argentina Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Columbia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Chile Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Venezuela Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Peru Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Puerto Rico Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Figure Ecuador Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume from 2017 to 2022
Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume and Growth Rate Forecast (2023-2028)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume Forecast by Regions (2023-2028)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Value Forecast by Regions (2023-2028)
Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Canada Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Canada Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Mexico Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Mexico Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure East Asia Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure China Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure China Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Japan Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Japan Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure South Korea Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure South Korea Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Germany Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Germany Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure UK Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure UK Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure France Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure France Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Italy Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Italy Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Russia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Russia Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Spain Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Spain Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Netherlands Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Netherlands Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Swizerland Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Swizerland Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Poland Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Poland Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure South Asia a Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure India Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure India Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Pakistan Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Pakistan Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Bangladesh Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Bangladesh Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Indonesia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Indonesia Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Thailand Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Thailand Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Singapore Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Singapore Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Malaysia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Malaysia Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Philippines Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Philippines Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Vietnam Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Vietnam Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Myanmar Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Myanmar Gastrointestinal Stromal Tumor (GIST) Drug Value and Growth Rate Forecast (2023-2028)
Figure Middle Eas
